Signia announced the launch of its newest lineup of Motion Charge&Go X hearing aids, which includes the Motion Charge&Go SP X – said to be the “first-ever rechargeable super power hearing aid that delivers uncompromised hearing with up to 61 hours of run-time per charge.” The Motion Charge&Go SP X, and its rechargeability, helps “ensure that even individuals with severe-to-profound hearing loss can enhance their human performance through improved hearing in every situation.”
This joins two other all-new Motion hearing aids – Motion Charge&Go P X and Motion Charge&Go X – to complete Signia’s latest lineup of Motion Charge&Go behind-the-ear (BTE) hearing solutions that are said to address “all levels of hearing loss.”
“Those with moderate to severe hearing loss depend heavily on their hearing aids – and not just for catching the total at the grocery checkout line or the specials at a restaurant, but for the real connections and sounds that give life meaning,” said Dr Tish Ramirez, Signia’s Vice President of Professional Relations and Product Management. “Signia Motion X delivers industry-best rechargeability and connectivity to ensure wearers stay better connected to their world without any limitations. Motion X hearing aids don’t just provide better hearing, they help provide a better life.”
Motion Charge&Go SP X is said to have up to 61 hours per charge, according to Signia, and is “the world’s most powerful rechargeable hearing aid.” The Motion Charge&Go P X offers up to 30 hours per charge, while the Motion Charge&Go X offers up to 24 hours per charge.
Signia Motion Charge&Go X: A new era in hearing technology
Signa’s “first-of-its-kind acoustic-motion sensor technology” is said to recognize one’s movements and adjusts sounds accordingly to ensure hearing in any situation is as precise and personalized as possible. Signia’s world’s-first OVP is a cutting-edge technology that processes the wearer’s voice separately from other sounds, leading to higher user satisfaction with the sound of their own voice.[1]
The Signia app provides access to hearing aid controls, streaming capabilities, tinnitus therapy, the Signia Assistant for a more personalized listening experience, and 24/7 digital support, Signia Telecare for remote care support, Signia Face Mask Mode for better speech understanding through masks, and much more.
Furthermore, the Xperience fitting (XFit) strategy helps offer a choice between more linear and more compressive gain settings for those with moderate-to-profound hearing loss. With the Dynamic Soundscape Processing slider, the wearer can “easily find a preferred balance of sound for best performance.” Additionally, the AI-based Signia Assistant helps allow the wearer to be more involved in actively shaping the sound quality of their own hearing aid.
All three models of Motion Charge&Go X offer Li-ion charging, Bluetooth connectivity, and an optional telecoil. They are available in all performance levels and can be ordered with an optional charger upgrade that includes a UV Dry&Clean function.
“Signia has invested heavily in developing first-of-its-kind, industry-leading technologies – across rechargeability, connectivity, speech intelligibility, and more,” said Ramirez. “However, this investment has been made with the sole aim of creating hearing solutions that prove people don’t have to be limited by their hearing loss – and that with one’s hearing restored, there’s nothing holding them back from performing their best.”
https://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.png00adminhttps://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.pngadmin2021-03-17 18:02:252021-03-17 18:02:25Signia Launches Motion X Hearing Aids
Phonak, a global provider of hearing solutions, announced Naída Paradise, the power hearing aid that “gives people with severe-to- profound hearing loss the power, sound quality, and wireless connectivity they need to connect with everything around them.” Now in its seventh generation, Naída Paradise is said to be “14% smaller, 27% lighter1, and further improves upon the hearing performance that wearers expect from Phonak.” This includes “powerful sound, industry-leading connectivity, and soon a new custom program memory feature with the new myPhonak 5.0 app.”
Phonak Naida Paradise and Roger On
Naída Paradise features a powerful double receiver that delivers up to 141 dB of peak gain in the UP model and up to 130 dB in the rechargeable model, according to Phonak. It’s powered by the new PRISM sound processing chip and features AutoSense OS 4.0 for “a host of premium features that work together seamlessly.” For example, the hearing aids can “automatically enhance soft speech in quiet places or reduce noise in loud environments.” A built-in accelerometer detects movement and automatically steers the microphones to improve listening on-the-go.2
Phonak Naida Paradise
Naída Paradise helps eliminate connectivity barriers that previously existed for consumers who needed more power. With Phonak universal connectivity, wearers can wirelessly stream audio directly into both hearing aids from virtually any smartphone, TV, laptop, tablet, eBook, and more. Phonak Paradise technology helps allow two active Bluetooth connections at the same time, so wearers can stay connected to their smartphone and their video chat without having to manually switch back and forth.
In addition to universal Bluetooth connectivity, Naída Paradise hearing aids are also equipped with RogerDirect. This means wearers can also receive the Roger remote microphone signal with no additional accessory required. Launched in 2013, Roger™ technology is “proven to boost hearing performance in loud noise and over distance.” In fact, hearing aid wearers who receive the Roger signal have better speech understanding in noise and over distance than people with normal hearing.3 Some Roger microphones and receivers have also been shown to help users understand up to 61% more speech in a group conversation in 75dBA of noise than using hearing aids alone.4
Universal Bluetooth connectivity coupled with on-board microphones means Naída Paradise wearers can use their hearing aids as wireless headsets for hands-free calls. A new Tap Control2 feature allows users to double tap on their ear to accept or end a call, or pause or resume streaming. A tap on the other ear gives access to smartphone voice-assistants like Siri or Google Assistant.
“Naída has a long-lasting history of delivering power without sacrificing sound quality, so we knew that we needed to deliver an outstanding product to our wearers who depend so heavily on their devices,” said Jon Billings, Vice-President Phonak Marketing. “With Naída Paradise, we’re making history again by giving those with severe forms of hearing loss access to next-level, powerful sound with industry-leading connectivity.”
In late spring, the myPhonak app’s 5.0 update will include the myPhonak Memory feature. It helps allow consumers to save a custom program from the app to the hearing aids, access the last-used custom program using the hearing aid’s multi-function button, or access other custom programs via the app.
Phonak is also preparing for the newest member of the Roger family with the debut of Roger On. The new Roger On remote microphone will feature MultiBeam 2.0 technology and an “improved pointing mode that allows the user to zoom into a speaker by simply pointing.” Roger On will be compatible with most hearing aids and cochlear implants and will be able to stream a variety of audio content.
The new Phonak Naída Paradise is available for pre-order by licensed hearing care professionals in the US and other select markets and will begin shipping in late February. The myPhonak 5.0 app featuring myPhonak Memory feature as well as the new Roger On microphone will be introduced in the US and other select markets in late spring.
Primary progressive aphasia is a rare neurodegenerative condition characterized by prominent language problems that worsen over time. About 40% of people with the condition have underlying Alzheimer’s disease. But a new study has found that people with the condition may not develop the memory problems associated with Alzheimer’s disease. The study is published in the January 13, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology (AAN). A summary of the research was also published on the AAN website.
“While we knew that the memories of people with primary progressive aphasia were not affected at first, we did not know if they maintained their memory functioning over years,” said study author M. Marsel Mesulam, MD, of Northwestern University Feinberg School of Medicine in Chicago and a Fellow of the American Academy of Neurology. “This has been difficult to determine because most memory tests rely on verbal skills that these people have lost or are losing.”
The study included 17 people with primary progressive aphasia associated with Alzheimer’s disease. They were compared to 14 people who had typical Alzheimer’s disease with memory loss.
Keynsham hearing centre
Researchers tested memory skills of the people with primary progressive aphasia by showing them pictures of common objects. After waiting 10 minutes, they were shown the same pictures along with others and had to indicate whether they had seen the picture before. This test was given once and then again an average of 2.4 years later. The people with typical Alzheimer’s disease listened to a list of common words and were later given the same words along with others and asked to choose the ones they had heard before. They were tested once and then again an average of 1.7 years later.
Both groups also had tests of their language skills. Brain scans were taken of the people with primary progressive aphasia to look at how the disease was affecting their brains, especially in the areas related to memory.
The people with primary progressive aphasia had no decline in their memory skills when they took the tests a second time. At that point, they had been showing symptoms of the disorder for an average of six years. In contrast, their language skills declined significantly during the same period. For the people with typical Alzheimer’s disease, their verbal memory and language skills declined with equal severity during the study.
Researchers had brain autopsies from eight of the people with primary progressive aphasia and all of the people with typical Alzheimer’s disease. The people with primary progressive aphasia had similar amounts of the plaques and tangles that are signs of Alzheimer’s disease as the people with typical Alzheimer’s, Mesulam said. Left sided asymmetry of brain shrinkage and a lower incidence of brain proteins known as ApoE4 and TDP-43 were identified as potential contributors to the preservation of memory in this rare type of Alzheimer’s disease.
“More research is needed to help us determine what factors allow these people to show this resilience of memory skills even in the face of considerable Alzheimer’s disease pathology in the brain,” Mesulam said.
Bristol Microsuction
Limitations of the study are the relatively small sample size and that autopsies were not available for all of the primary progressive aphasia cases.
Original Paper: Mesulam MM, Coventry C, Kuang A, et al. Memory resilience in Alzheimer’s disease with primary progressive aphasia. Neurology. 2020. DOI: https://doi.org/10.1212/WNL.0000000000011397.
Oticon Launches Oticon More at 2021 OticonNext Event
Oticon announced that over 5,000 hearing care professionals registered to join the company for its 2021 OticonNext “Discover More” Conference, the company’s “biggest ever launch event for a new product.” The live, virtual knowledge-sharing experience introduced participants to Oticon More, “the world’s first hearing aid with an on-board deep neural network.” This new hearing aid is said to build on Oticon’s “proven BrainHearing approach to deliver a full and precisely balanced sound scene that makes it easier for the brain to perform optimally.” Oticon President Gary Rosenblum and Oticon staff experts showed conference participants how Oticon More represents a “fundamentally new approach” to signal processing.
“Through the OticonNext Conference, we aimed to equip practitioners with the knowledge and tools they need to continue to bring life-changing technology to patients,” said Rosenblum. “Over the past decade, Oticon has pioneered new standards and advanced its portfolio of hearing solutions dramatically. From our newest addition, Oticon More, to our innovative power and pediatric solutions, we continue to offer hearing care professionals and their patients one of the industry’s most comprehensive portfolios of hearing technology.”
Rosenblum shared recent honors for the new hearing solution with conference participants. On January 11, the Consumer Electronics Association named Oticon More an honoree in the CES 2021 Innovation Awards in the Health & Wellness and Wearable Technologies categories. This is the fifth consecutive year that Oticon, Inc has been recognized by the international awards program that annually selects the best of the best in consumer electronics. The most recent awards bring to an even dozen the number of times Oticon has been honored by the CES InnovationAwards program.
Inspiration, Innovation, and Practice Support
Keynote speaker Dan Buettner, author of The Blue Zones: Lessons for Living Longer from the People Who’ve Lived the Longest, provided guidance on how technology like Oticon More contributes to health and long life by enabling patients to maintain vital connections to people and the world. A panel discussion addressed questions from the online audience on Oticon More’s technology innovations, including the new Polaris platform. Following the conference, hearing care professionals were invited to explore The Zone exhibit hall to learn more about the variety of clinical and business support available through Oticon and the company’s business partners.
Interactive Webisodes Continue Knowledge Sharing
The conference’s interactive virtual format extends beyond the launch event with a series of post-conference educational webisodes that build on the knowledge gained at OticonNext. The live interactive sessions take a deeper dive into the audiology of Oticon More and the new research that shows the brain needs access to all sounds—not just speech—in order to work in a natural way. Scheduled for February and March, the five webisodes each last approximately one hour and require prior registration.
Learn more about Oticon More and the entire portfolio of Oticon hearing solutions with BrainHearing technology at: www.Oticon.com/More.
https://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.png00adminhttps://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.pngadmin2021-01-20 10:49:282021-01-20 10:49:28Oticon hearing aids
Neurophysiologists at the University of Connecticut (UConn) have discovered a new drug that may prevent tinnitus and treat epilepsy by selectively affecting potassium channels in the brain. According to an article in the June 10, 2015 edition of The Journal of Neuroscience, Anastasios V. Tzingounis, PhD, and colleagues say that both tinnitus and epilepsy are caused by overly excitable cells that flood the brain with an overload of signals that can lead to seizures (epilepsy) or phantom ringing in the ears (tinnitus).
The authors report that roughly 65 million people worldwide are affected by epilepsy. While exact statistics on tinnitus are not easy to determine, the American Tinnutus Association estimates that two million people in the US suffer from disabling tinnitus.
Anastasios V. Tzingounis, PhD, University of Connecticut
According to Tzingounis and co-authors, the existing drugs available to treat epilepsy don’t always work and can have serious side effects. One of the more effective drugs, retigabine, helps open KCNQ potassium channels, which serve as the “brakes” that shut down the signaling of overly excited nerves. Retigabine, however, has terrible side effects and is usually only given to adults who don’t get relief from other epilepsy drugs. The side effects of retigabine include sleepiness, dizziness, problems with hearing and urination, and a disturbing tendency to turn patients’ skin and eyes blue.
In 2013, Tzingounis began collaborating with Thanos Tzounopoulos, PhD, a tinnitus expert at the University of Pittsburgh, to create a new drug candidate. The new drug, SF0034, was chemically identical to retigabine, but included an extra fluorine atom. Originally developed by SciFluor, the company wanted to know whether the compound had promise for treating epilepsy and tinnitus.
Thanos Tzounopoulos, PhD, University of Pittsburgh
Tzingounis and Tzounopoulos thought the drug had the potential to be much better than retigabine in treating both conditions. They first had to determine if SF0034 worked on KCNQ potassium channels the same way retigabine does, and if so, if it would be better or worse.
The co-authors explain in their article that KCNQ potassium channels are found in the initial segment of axons, long nerve fibers that reach out and almost touch other cells. The gap between the axon and the other cell is called a synapse. When the cell wants to signal to the axon, it floods the synapse with sodium ions to create an electrical potential. When that electrical potential goes on too long, or gets overactive, the KCNQ potassium channel kicks in. The result is that it opens, potassium ions flood out, and the sodium-induced electrical potential shuts down.
In some types of epilepsy, the KCNQ potassium channels have trouble opening and shutting down runaway electrical potentials in the nerve synapse. Retigabine helps them open. According to the authors, there are five different kinds of KCNQ potassium channels in the body, but only two are important in epilepsy and tinnitus: KCNQ2 and KCNQ3. The problem with retigabine is that it acts on other KCNQ potassium channels as well. That’s why it has so many unwanted side effects.
When testing SF0034 in neurons, the researchers found that it was more selective than retigabine. It appeared to open only KCNQ2 and KCNQ3 potassium channels, and to not affect the KCNQ 4 or 5 potassium channels. The research showed that SF0034 was more effective than retigabine at preventing seizures in animals, and it was also less toxic.
The results are promising, and SciFluor plans to start FDA trials with SF0034 to test its safety and efficacy in people. Treating epilepsy is the primary goal, but treating or preventing tinnitus is a secondary goal.
https://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.png00adminhttps://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.pngadmin2021-01-09 15:22:002021-01-09 15:22:00New Drug Promises Relief from Tinnitus
Zoom Charges Monthly Fee for Closed Captioning During Pandemic, ‘WBFO’ Reports
The challenges for hearing impaired people working remotely and utilizing video conferencing services during the coronavirus pandemic can make communication difficult. According to an article on the WBFO/NPR website, hearing advocate and Living With Hearing Loss founder Shari Eberts recently wrote an open letter—that turned into a petition with 58,000 signatures—asking video conferencing companies to remove the paywall from their captioning services.
According to the article, both Google and Microsoft have complied, but Zoom is still charging a $200 monthly fee for users to be able to access closed captioning.
Issues with video conferencing that include poor audio and/or sound quality as well as spotty internet connection, can make lip reading difficult. Even when using workarounds like speaker mode to be able to see a larger version of the person they’re speaking with and/or headphones to improve sound quality, a person’s lips can be out of sync with their words, Eberts says in the article. Closed captions could improve communication in these situations, she says.
“It’s hard for us to want to jump in or to share our thoughts because we’re not sure what’s been said. And obviously, there’s a lot of trepidation about looking silly or repeating something that someone just said,” Eberts is quoted in the article as saying.
To read the article in its entirety, please click here.
Whisper may have a quiet name, but it could reverberate loudly in the hearing healthcare industry. The company launched its first new hearing aid on October 15—a product that really is significantly different from all others dispensed by audiologists and hearing aid specialists. And, yes, that’s right: the Whisper Hearing System is designed for dispensing by hearing care professionals. As such, Whisper represents the first new major hearing aid manufacturer with a product specifically designed for dispensing since the InSound Medical XT was approved by the FDA in 2003 (later purchased in 2010 by Sonova and renamed Lyric).
The Whisper RIC hearing aids and brain.
And a bit like Lyric, Whisper will use a subscription payment model for consumers. The leasing concept is gaining ground in hearing healthcare, in part due to the fact that technology moves so fast, hearing aids can be expensive, and frequent product upgrades are now a given in the industry. Whisper will be available via a comprehensive monthly plan that includes ongoing care from a local hearing care professional, a lease of the Whisper Hearing System, regular software upgrades, and a 3-year warranty that not only covers the system itself but also loss and damage. The company is offering a special introductory rate of $139/month (regularly $179/month) for a 3-year term.
The New Whisper Hearing System
The Whisper Hearing System essentially has three components:
A hearing aid processor that resembles an advanced receiver-in-the-canal (RIC) hearing aid;
The Whisper Brain is a small device that runs an AI-driven Sound Separation Engine to optimize sound in real time. It also enables connectivity to iPhones, and
A phone app that provides an interface for the consumer.
The Whisper team, which is largely composed of executives from the AI field, created the Whisper brain as a dedicated, powerful sound processing system that also allows for updates and other capabilities—instead of relying on the wearer’s smartphone for many of these functions. “We developed the Whisper Brain to run the core technology we’ve developed for hearing,” said company Co-founder and President Andrew Song in an interview with Hearing Review. “Think about your smartphone and all the processing inside it. We’re using the Whisper Brain to apply this type of processing to hearing without having to compete with smartphone games or applications. The Whisper Brain is a dedicated processor designed to provide the best hearing.”
However, the Whisper Brain isn’t required to use the hearing aid, as there may be situations where the wearer wants to step away from it or not take it with them. In those situations, the hearing aid uses the “onboard” hearing aid algorithms in the RIC (similar to other advanced hearing aids when unpaired to the user’s cell phone).
Wireless connectivity with iPhones is also provided through the Whisper Brain via Bluetooth, and the company says it may support other phones and has plans to expand on this in the future. The RICs use a size 675 battery with an expected use of 4-5 days with typical use including streaming, and the WhisperBrain has a USB port for recharging.
Not Your Grandfather’s Hearing Aid
Andrew Song
According to Song, Whisper started about 3 years ago in San Francisco when he began discussions with another Whisper co-founder, Dwight Crow, the company’s CEO. Song is the former head of products for an online instant-messaging (IM) system most of us are familiar with: Facebook Messenger Core. A mathematics and computer science graduate of the University of Waterloo, he is an expert in artificial intelligence and a member of Sequoia Capital’s Scout Program which was formed to discover and develop promising companies. Crow is the founder of Carsabi, a machine-learning based car sales aggregator acquired by Facebook in 2012, and he helped build the e-commerce segment at Facebook which yields over $1 billion per quarter in revenue. A third co-founder, Shlomo Zippel, was the applications team leader at PrimeSense which built the 3D sensor technology behind Microsoft Kinect.
Jim Kothe
The company then added as head of sales Jim Kothe, an audiologist and hearing industry veteran who has a wealth of experience within both the dispensing community and manufacturing, in addition to an extremely impressive team of executives with experience and leadership roles at companies like Facebook, Nest, Google, Invisalign, Johnson & Johnson, Solta Medical, and Cutera. Together they are collaborating on a product that blends artificial intelligence, hearing care, hardware, and software for helping solve the challenge of providing better hearing.
“I think for me, and probably for everyone at the company, it’s a very personal mission,” says Song. “Personally, the starting point is really my grandfather. He has hearing loss and is not an uncommon story when you work in this business: I’d say that he’s a hearing aid owner, but not a hearing aid wearer.”
This set into motion Song’s investigation into what hearing aid technology was doing, what experiences people were having with it, and why his grandfather had the complaints he did. “That really opened my world to all the exciting things that could be done, but also the opportunity we have for how we can really build a product to help [people like him],” says Song. “Since then we’ve been putting the product together and bringing the expertise that comes from hearing folks like Jim and the others on our team—and blending it with the kind of product and technology ideas we almost take for granted here in Silicon Valley. Products are becoming more consumer friendly, more consumer oriented, and we’re building some of those ideas into a new type of hearing aid product. So, while Whisper is a hearing aid regulated by the FDA, all of these things influenced our approach, our mentality, and our vision towards this space, and we think our approach is a little different [from those of other hearing aid manufacturers].”
The larger capacity for processing power is extremely exciting for Song and his colleagues, and he likens this advancement to the leap from analog to digital hearing technology.
The larger capacity for processing power is extremely exciting for Song and his colleagues, and he likens this advancement to the leap from analog to digital hearing technology. He says some great hearing aid algorithms have been, and will continue to be, created that will result in substantially improved hearing. However, there’s little point in having these algorithms if they can’t be fully employed in a wearable device.
He also says the problem in hearing aids is much more complex than, for example, those solutions found in noise-cancelling headphones. “Over time, [we’ve had] very ambitious people with a lot of ideas on what we should do with this powerful processing. What’s really exciting is not just having this technology, but also having a learning platform to be able to develop it. I think one of the most interesting parts of development is that the goal, at the end of the day, really isn’t about perfect noise removal. You need noise in your life. We have demos we can run that more or less perfectly remove noise…and it just creates sort of a weird environment. So, I think in many cases, the unique aspect of what we’re doing revolves around how do we use [the research] and how do we invent some truly novel ideas? Obviously, it’s not only about noise removal, but how we can use the powerful processing specifically in these hearing aids to make hearing aids really good for the purpose of listening. That subtlety is where we feel like we can really differentiate ourselves and truly make a difference in people’s lives.”
A System that Relies on Professional Care
Song says there has been a patient-centric approach at every turn in the design, development, marketing, and especially distribution of the Whisper Hearing System. And it starts with the hearing care professional’s expertise.
“I think there’s several very important things along that path; the first of which was to work with hearing care professionals who are the ‘artists’ in delivering great care,” Song told HR via a Zoom interview. “If I look at my grandfather’s experience, it was pretty obvious to me that having the right professionals made a huge difference. And so you can talk about using Zoom or you can talk about going direct to consumer, but it’s very, very obvious—even as a Silicon Valley engineer—that the audiologist is extremely important in the process. That’s why we made a decision very early on that we’d be working with professionals. And if you remember, when the company started in 2017, that’s when the OTC laws were getting passed. That’s where all the ‘cool stuff’ was supposed to be. Everyone was saying, ‘Get rid of these professionals!’ …But there’s a care-oriented mindset in hearing healthcare. You can see that there’s a personal aspect [needed] to evaluate what would be good for my grandfather. And when you talk to patients and you talk to audiologists, this becomes very clear. So, I think that was a very early decision that’s not necessarily about the product, per se, but about our business and how we best deliver the hearing system.”
One of the things Whisper also wants to address is the post-purchase feeling of regret that can accompany a high-end, high-technology purchase. As with any car, computer, or consumer electronics device, when a consumer purchases an expensive top-of-the-line hearing aid, there is doubtlessly a more advanced model with new processing capabilities and features that will be launched 6 months later. But, with hearing loss, Song believes that sense of regret can be magnified because hearing is such a personal, important 24/7 activity.
The Whisper Hearing Aid Brain
That led to the idea of a subscription-based system using a machine-learning platform that can be upgraded on regular intervals without continually replacing the actual hearing aid or brain itself. “The nature of our product is that it gets better over time. You don’t need to pay for [the upgrades]; the hearing aid learns on its own, and we’ll also deliver you a software upgrade every few months. [It’s] similar to how you might think of a cell phone plan…Fundamentally, that’s really what we’re trying to offer.”
It’s also important that professionals have the margins and revenues to be able to cover their expenses in order to provide exceptional hearing care, says Song. Whisper plans to provide upfront fees and work with professionals, while offering patients a better way to pay for the product, support, and systems that the company has developed. Currently, a select number of hearing care professionals are using the Whisper Hearing System, and the company is now expanding from this base of dispensing offices.
When asked how he thinks Whisper will change the hearing aid market, Song quickly replied, “I really hope that everybody around the world gets an upgradable hearing aid in the next 5 years. And, of course, I hope it’s ours. We have a lot to offer. But if the market moves toward Whisper in 5 years, then we’re competing with everybody to make the best upgrades. Frankly, I think that’s a big win for the industry. And it’s also a big win for my grandfather, right? I think, as part of that vision, we have to be really mindful about how much we bite off in any of our product development. So this first product represents a first step, especially on the device with this kind of learning capability and working with professionals on this payment model—all of the new things that we’ve already talked about. But there are other aspects around this kind of patient-centric, consumer-centric model with the professional and I think there’s a lot of interactivity that we can build on. There’s a lot of new ideas we have about how to better integrate everything together. And so, more and more, we’ll be able to build that out and address those issues because we’ll have an excellent learning hearing aid on the market.”
Funding for Whisper
The initial investment to establish the company came from Sequoia Capital and First Round Capital, and on Thursday (October 15) Whisper announced the close of a $35 million Series B funding round led by Quiet Capital for total funding of $53 million. Advisors for the company include Mike Vernal of Sequoia and former VP of engineering at Facebook; audiologist Robert Sweetow who is the former UCSF Director of Audiology; Lee Linden of Quiet Capital and founder of TapJoy and Karma; Rob Hayes of First Round which also invested in Uber and Square, and Stewart Bowers, former VP of engineering at Tesla who was responsible for AutoPilot.
“Software-defined hearing technology is the future,” said Vernal in a press statement. “By building the Whisper Hearing System around software, the Whisper team will be able to improve patient care with a device that adapts, upgrades, and improves continuously for the wearer’s benefit. This is the start of a new paradigm for delivering hearing technology, and we’re thrilled to partner with Whisper on this journey.”
“What I look for in a company is the team,” said Hayes. “The Whisper team combines incredible expertise in cutting edge artificial intelligence, software, and hardware with a genuine passion for helping people. I’m excited to work with them to transform the hearing space.”
BBC Looks at How Loud Music Can Lead to Early Signs of Hearing Damage
Those who frequently attend loud concerts and music events may be more likely to have earlier signs of hearing damage according to an article in BBC Science Focus Magazine.
The article examined a study from researchers at the University of Manchester, which suggests that although the damage observed is not enough to be diagnosed as a full-blown hearing loss, it could potentially have a cumulative effect on hearing later in life. Out of the 123 people tested, researchers found that those exposed to loud music had less functional hair cells.
To prevent this kind of damage, the researchers suggest avoidance of noisy situations, reduction of volume, or the use of hearing protection such as earplugs or earmuffs.
https://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.png00adminhttps://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.pngadmin2020-09-21 10:31:142020-09-21 10:31:14Loud Music Can Lead to Early Signs of Hearing Damage
University of Auckland to Study Chatbot Technology for Potential Tinnitus Therapy
Chatbot technology that offers therapy for tinnitus sufferers via a mobile device such as a smartphone will be trialed at the University of Auckland, according to an announcement on the school’s website.
Researchers are recruiting participants for the “Tinnibot” study which is aimed at helping those who suffer from a hearing disorder that affects around one in ten New Zealanders and more than 700 million people worldwide.
Tinnitus is usually experienced as a ringing in the ears but sufferers report a range of noises including buzzing, clicking, and even the sound of cicadas. Severity varies: sounds can be continuous or intermittent but the condition is linked to serious mental health effects including depression, anxiety, and insomnia. Currently there is no cure.
But as online technologies and devices such as smartphones change the way health care is delivered, Dr Fabrice Bardy from the University of Auckland’s School of Psychology says it has created new opportunities to treat tinnitus and to study which treatments work best.
Dr Fabrice Bardy
Tinnibot is a chatbot program which uses Cognitive Behavioural Therapy (CBT), proven to be effective in the treatment of tinnitus but usually only available through one-on-one sessions which can be expensive and involve long wait times.
The chatbot’s software interface delivers CBT designed for an individual’s needs directly to their mobile, conducting an automated and interactive text conversation designed to help people regulate their thoughts by focusing on positive thoughts and challenging negative ones.
The interface incorporates a sound therapy library which has proved to be effective tinnitus therapy, particularly for those who have trouble sleeping. It works by using noise at just the right volume to drown out the sounds tinnitus can produce.
Keynsham hearing centre
Dr Bardy describes Tinnibot to be like having a tinnitus expert in your pocket.
“This chatbot interface is the first one designed specifically for the treatment of tinnitus, a tool that offers direct therapy and support which is convenient and affordable,” he said. “It will help people better understand their condition and to manage symptoms, give them a sense of being in control, and a confidence boost because that’s an important part of successful treatment.”
Participants in the research will be split into two cohorts with one using Tinnibot only and the other using Tinnibot as well as video counseling with a psychologist. The aim is to see which treatment is more effective.
If you have been bothered with tinnitus for over three months and if you are interested in participating in the study, contact Dr Bardy for more information.
Oticon Launches Ruby Hearing Aid for Budget-Conscious Patients
For consumers returning to work and social activities in an uncertain economic climate, the newest addition to Oticon’s line of technology offers a combination of “sound quality, sought-after features, and affordability,” according to an announcement from the company. The new Oticon Ruby “sets a new standard in the essential category, delivering great sound quality, hassle-free rechargeability, and easy wireless connectivity in one complete solution—all within the reach of today’s budget-conscious patients.”
Powered by the Velox S platform, Oticon Ruby introduces the new SuperShield feedback management system that “helps prevent feedback before it occurs, so patients can enjoy hearing without interruptions from unwanted whistling and squealing.” For patients who want the convenience of rechargeable batteries, a new lithium-ion rechargeable option helps provide a full-day’s* charge in a few hours. Bluetooth connectivity helps enable patients to connect to smartphones and other modern devices to stream audio and music directly to their hearing aids.
“After experiencing this time of social distancing, consumers recognise the value of easy access to modern technologies to stay connected with family, friends, and business colleagues,” said Don Schum, PhD, Vice President of Audiology for Oticon, Inc. “Phone calls, video chats, and other virtual connections have become their lifeline to the world. These connections are enhanced with better hearing. At the same time, despite the start of an economic recovery, some patients may be more careful about spending. Oticon Ruby allows practitioners to offer patients looking for sought-after features, like rechargeability and easy wireless connections, a quality solution at a more affordable price.”
Like all Oticon wireless hearing aids, Oticon Ruby is compatible with Oticon RemoteCare, a new telehealth solution that allows hearing care professionals to follow up online with patients to remotely adjust and fine-tune hearing aids in a virtual appointment. For select patients who have valid audiograms, first fit with Oticon RemoteCare allows hearing care professionals to fit new hearing aids remotely.
Bath hearing centre
Oticon Ruby and all Oticon hearing aids use BrainHearing technology to “help support the brain in making sense of sound and enable patients to participate in challenging listening environments.” The Velox S platform powers the new SuperShield technology to analyse incoming sound levels, identify feedback, and prevent whistling before it occurs.
Oticon Ruby miniRITE R rechargeable hearing aids offer a full day* of power with an overnight charge. The charger helps provide a stable, reliable magnetic connection for charging that delivers power throughout the day, including streaming, with a three-hour charging time. A 30-minute recharge provides an additional six hours of power, according to Oticon.
With 2.4 GHz Bluetooth low-energy technology, Oticon Ruby helps deliver “easy wireless connectivity with low battery consumption to a wide range of devices such as smartphones, audio or music streams in stereo to both hearing aids from Bluetooth-connected mobile phones, MP3 players, PCs, and more.” Patients can pair Oticon Ruby with multiple TV Adapters and use the Oticon ON App to stream from any TV. The Oticon ON App also lets patients adjust volume, switch settings, check battery level, and access features such as Find My Hearing Aid and Oticon HearingFitness.
Keynsham ear wax removal
Oticon Ruby is available in a full lineup of styles, including miniRITE, miniRITE T (telecoil), miniRITE R (rechargeable), BTE and BTE Power Plus, and five popular colours. Oticon Ruby is compatible with Oticon CROS hearing aids.
https://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.png00adminhttps://www.keynshamhearing.co.uk/wp-content/uploads/2019/03/logo-300x79.pngadmin2020-07-20 11:51:082020-07-20 11:51:08Oticon Launches Ruby Hearing Aid for Budget-Conscious Patients
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
